Browse > Article
http://dx.doi.org/10.7845/kjm.2018.8052

Diagnosis of Clostridium difficile infection in patients with hospital-acquired diarrhea  

Ibrahim Afifi, Salwa Selim (Faculty of Pharmacy-Girls, Al-Azhar University, Microbiology and Immunology)
Gomaa, Fatma Alzahraa M. (Faculty of Pharmacy-Girls, Al-Azhar University, Microbiology and Immunology)
Fathi, Lamia Fouad (Ain Shams Faculty of Medicine, Medical Microbiology and Immunology)
Rasslan, Fatma Salah (Faculty of Pharmacy-Girls, Al-Azhar University, Microbiology and Immunology)
Hamdy, Ahmed Mohamed (Ain Shams Faculty of Medicine, Pediatrics)
Publication Information
Korean Journal of Microbiology / v.54, no.3, 2018 , pp. 214-221 More about this Journal
Abstract
Clostridium difficile infection (CDI) is a rapidly emerging infection that may have devastating consequences. Prompt and accurate diagnosis is crucial for management and control. The aim of this study was to determine the incidence of C. difficile associated diarrhea among hospitalized patients, and to compare different diagnostic laboratory methods for detection of toxin producing strains in clinical specimens. The study was conducted at a university hospital in Cairo during the period from May 2013 till June 2015. Subjects were under antibiotic therapy and presented with hospital-acquired diarrhea. Four hundred and sixty-five stool specimens were processed by different microbiological methods. C. difficile was recovered in culture in 51 of stool specimens. Of these, 86.3% to 98% were positive for toxin production by 2 different methods. This study showed that antibiotic intake is the major risk factor for development of hospital-acquired diarrhea. We evaluated different microbiological methods for diagnosis of C. difficile. We recommend the use of toxigenic culture as a gold standard for microbiological diagnosis of C. difficile.
Keywords
Clostridium difficile; hospital-acquired diarrhea;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Silva RO, Ribeiro MG, Palhares MS, Borges AS, Maranhao RP, and Silva MX. 2013. Detection of A/B toxin and isolation of Clostridium difficile and Clostridium perfringens from foals. Equine Vet. J. 45, 671-675.   DOI
2 Silva ROS, Vilela EG, Neves MS, and Lobato FCF. 2014. Evaluation of three enzyme immunoassays and a nucleic acid amplification test for the diagnosis of Clostridium difficile-associated diarrhea at a university hospital in Brazil. Rev. Soc. Bras. Med. Trop. 47, 447-450.   DOI
3 Solomon K, Martin AJ, O'Donoghue C, Chen X, Fenelon L, Fanning S, Kelly CP, and Kyne L. 2013. Mortality in patients with Clostridium difficile infection correlates with host pro-inflammatory and humoral immune responses. J. Med. Microbiol. 62, 1453-1460.   DOI
4 Argamany JR, Aitken SL, Lee GC, Boyd NK, and Reveles KR. 2015. Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010. Am. J. Infect. Control 43, 435-440.   DOI
5 Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, et al. 2014. Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management? Clin. Microbiol. Infect. 20, 136-144.   DOI
6 Barkin JA, Nandi N, Miller N, Grace A, Barkin JS, and Sussman DA. 2012. Superiority of the DNA amplification assay for the diagnosis of C. difficile infection: A clinical comparison of fecal tests. Dig. Dis. Sci. 57, 2592-2599.   DOI
7 Johnson EA, Summanen P, and Finegold SM. 2007. Clostridium. In Manual of clinical microbiology, 9th edn. Pfaller Washington, DC, USA.
8 Tenover FC, Baron EJ, Peterson LR, and Persing DH. 2011. Laboratory diagnosis of Clostridium difficile infection. J. Mol. Diagn. 13, 573-582.   DOI
9 Stevens DL, Bryant AE, and Carroll KC. 2015. Clostridium, pp. 940-966. In Jorgensen JH, and Pfaller MA, Carroll KC, and American Society for Microbiology (eds.), Manual of clinical microbiology. 11th ed. ASM Press, Washington, D.C., USA.
10 Summanen P, Baron EJ, Citron DM, Strong CA, Wexler HM, and Finegold SM. 1993. Wadsworth anaerobic bacteriology manual, 5th edn. Star Publishing Co., Belmont, CA, USA.
11 Vincent C and Manges AR. 2015. Antimicrobial use, human gut microbiota and Clostridium difficile colonization and infection. Antibiotics 4, 230-253.   DOI
12 Planche T, Aghaizu A, and Holliman R. 2008. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect. Dis. 8, 777-784.   DOI
13 Kim H, Kim WH, Kim M, Jeong SH, and Lee K. 2014. Evaluation of a rapid membrane enzyme immunoassay for the simultaneous detection of glutamate dehydrogenase and toxin for the diagnosis of Clostridium difficile infection. Ann. Lab. Med. 34, 235-239.   DOI
14 Lalande V, Barrault L, Wadel S, Eckert C, Petit J, and Barbut F. 2011. Evaluation of a loop-mediated isothermal amplification assay for diagnosis of Clostridium difficile infections. J. Clin. Microbiol. 49, 2714-2716.   DOI
15 Mylonakis E, Ryan ET, and Calderwood SB. 2001. Clostridium difficile-associated diarrhea: a review. Arch Intern Med. 161, 525-533.   DOI
16 Ota KV and McGowan KL. 2012. Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays with C. difficile nucleic acid amplification testing increase diagnostic yield in a tertiary pediatric population. J. Clin. Microbiol. 50, 1185-1188.   DOI
17 Peterson LR, Mehta MS, Patel PA, Hacek DM, Harazin M, Nagwekar PP, Thomson RB, and Robicsek A. 2011. Laboratory testing for Clostridium difficile infection. Am. J. Clin. Pathol. 136, 372-380.   DOI
18 Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, O'Connor L, Oakley SJ, Pope CF, Wren MW, et al. 2013. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect. Dis. 13, 936-945.   DOI
19 Rineh A, Kelso MJ, Vatansever F, Tegos GP, and Hamblin MR. 2014. Clostridium difficile infection: molecular pathogenesis and novel therapeutics. Expert Rev. Anti. Infect. Ther. 12, 131-150.   DOI
20 Shilling MP. 2013. Ph. D. thesis. Optimizing detection and control of Clostridium difficile and its toxins. University of Kent State. USA.
21 Bomers MK, Menke FP, Savage RS, Vandenbroucke-Grauls CMJE, van Agtmael MA, Covington JA, and Smulders YM. 2015. Rapid, accurate, and on-site detection of C. difficile in stool samples. Am. J. Gastroenterol. 110, 588-594.   DOI
22 Dembek M, Barquist L, Boinett CJ, Cain AK, Mayho M, Lawley TD, Fairweather NF, and Fagan RP. 2015. High-throughput analysis of gene essentiality and sporulation in Clostridium difficile. mBio 6, e02383-14.
23 Brown NA, LeBar WD, Young CL, Hankerd RE, and Newton DW. 2011. Diagnosis of Clostridium difficile infection: comparison of four methods on specimens collected in Cary-Blair transport medium and tcdB PCR on fresh versus frozen samples. Infect. Dis. Rep. 3, e5.   DOI
24 Collee JG, Duguid JP, Fraser AG, and Marmion BP. 1989. In Mackie and macCartney practical medical microbiology 13th edn, Vol 2, Churchill Livingstone, Longman Group Ltd.
25 Collee JG and Marr W. 1996. Specimen collection, culture containers and media. In Collee JG, Fraser AG, Marmion BP, and Simmons A. (eds.), Mackie & macCartney practical medical microbiology. 14th edn. Churchill Livingstone.
26 Hansen G, Blatt S, Brecher SM, Dubberke E, and Dorsett P. 2010. Clinical laboratory news: Clostridium difficile. Clin. Lab. News 36, 10-13.
27 Humphries RM. 2012. Laboratory tests for the diagnosis of Clostridium difficile infections. Clin. Microbiol. Newsl. 34, 151-157.   DOI
28 Jamal W, Pauline EM, and Rotimi VO. 2014. Comparative performance of the GeneXpert C. difficile PCR assay and C. diff Quik Chek Complete kit assay for detection of Clostridium difficile antigen and toxins in symptomatic community-onset infections. Int. J. Infect. Dis. 29, 244-248.   DOI